NCM·Healthcare·$132M·#272 / 520 in Healthcare
RCEL Avita Medical, Inc.
41SPECULATIVE
CATEGORY BREAKDOWN
GROWTH18
QUALITY60
STABILITY38
VALUATION96
GOVERNANCE12
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+11.5%
18
> 50% strong
Gross Margin
Revenue retained after direct costs
82.1%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
4 months
7
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
-276.6%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.8x
96
< 3x strong
Rule of 40
Growth rate plus operating margin
-48
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
1.0%
8
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+16.4%
21
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE RCEL WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when RCEL's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.